imatinib mesylate has been researched along with Pulmonary Aspergillosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Langhe, E; Hillen, A; Himmelreich, U; Lories, RJ; Poelmans, J; Vande Velde, G; Vanoirbeek, J | 1 |
1 other study(ies) available for imatinib mesylate and Pulmonary Aspergillosis
Article | Year |
---|---|
Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume.
Topics: Animals; Biomarkers; Bleomycin; Cryptococcosis; Disease Models, Animal; Fibrosis; Imatinib Mesylate; Inflammation; Lung; Lung Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Aspergillosis; X-Ray Microtomography | 2016 |